Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
about
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.The behavioral pharmacology of hallucinogensActivation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortexActivation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytesGroup II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsPreclinical models of antipsychotic drug action.Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatmentRecent advances in the neuropsychopharmacology of serotonergic hallucinogensEpigenetic Mechanisms of Serotonin Signaling.mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in RatsPsychedelicsThe mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaPreclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.Serotonergic hallucinogens as translational models relevant to schizophrenia.Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primatesMetabotropic glutamate receptors: from the workbench to the bedside.Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.The 5-HT1A receptor and the stimulus effects of LSD in the rat.Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotionMaternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in miceTolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain.The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral CortexPharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugsPersistent effects of chronic clozapine on the cellular and behavioral responses to LSD in miceRegulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?Group II metabotropic glutamate receptors and schizophrenia.The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.Metabotropic glutamate receptors as therapeutic targets for schizophrenia.Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task.Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain.The Effects of Hallucinogens on Gene Expression.
P2860
Q24595389-671AFF1E-BB82-4AD3-BC31-45FF68CC2FC7Q24596842-6DD941B0-D1D5-41A5-8FC3-A1BDCC595C7DQ24645656-23E9D7E3-E7D8-44C7-84BE-C9BCDAC658F8Q24649779-89116A93-D3D8-4AE9-80BC-02BABE6A580CQ24652204-8099E942-B8B6-4C17-83F3-749EBAEBE364Q24671935-9D10CA39-E8AF-48CB-BA49-269D53318B76Q26744729-0174D540-F45F-48A5-A801-3899BC94E351Q26827502-E06D264F-6EF2-4B40-AAA8-16DA122B4247Q26852047-E65B50ED-4B41-445C-85FE-F858613EA72BQ27027381-A5CE7B0D-6175-4D7B-B91C-15FAB71735ECQ27027985-C7F949AB-7A9A-4A53-ABE7-CA9F03ADDDA8Q28551598-11E83923-E55C-46DF-9BB9-C980C00B8F90Q30359998-ADA617DD-2548-4E44-AC24-007984ECD0F9Q30371933-C4F8F038-4D08-450F-B082-1914A7B43537Q30418647-D32E524C-C0F9-4636-97C6-91EF8196629DQ30427074-4EB582F5-1998-4D24-9417-9DF8FC8AA27AQ30443072-3E8AFB09-868F-4209-AC29-E4B0235273D0Q30448778-A615AC35-D038-4FFB-AD6A-71D90A88F66AQ30559794-A4CB6089-361E-41B2-A4B1-AA2C39FBF515Q34099158-94104BA5-EF6D-4377-8320-C57058A69EC4Q34197072-B39E5F69-AED5-43F8-A1D7-28A66EA1B835Q34566313-632193AC-2F83-4E5B-85FD-0C084E9C8227Q34770846-9BB37ABF-FFF2-41E1-80F6-75583C98033CQ35024752-E2E0BFB2-C410-4DA5-9971-41383FE8BA58Q35080459-0C0B093C-4256-4CC3-AA60-4E5FD69C60D8Q35623415-274744D6-3E21-402D-A415-653BCF2C6FF6Q35760210-BD071078-BE54-4D16-8F7E-34C406291E08Q36307104-1E24371B-62C1-4328-AEA8-DB73E7D22395Q36493481-E80392DF-07B7-477D-A5BC-5E334D04C778Q36555130-3292B209-2ECF-4317-AEEE-A8AABA1D9344Q36755908-EEA5675A-1CF7-4987-B59E-4561A21E01CBQ36852536-5ADA5B6D-C82E-4FED-B3F3-987C16EF4D94Q36860053-8F9B8FCC-787F-4A2C-BC73-18C610BBF9E0Q37473779-A2F9729A-F587-49A2-94BB-158D64B2FF6CQ37826638-8725F6B7-CB2B-4000-8DBA-800FFC291CA2Q37881198-061FDD14-0E28-4855-ACB8-74FEC6D050A6Q38062443-45AC643C-F206-447C-AEAB-4100C341954BQ38223390-AE5AEDD8-A2C2-43D7-B759-42BE7A08AC3EQ39370168-B78457E4-99E3-4BB5-8A74-64C741219ACBQ39414457-343C186E-C917-4DAD-918B-DFB99C36D657
P2860
Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Behavioral evidence for intera ...... tabotropic glutamate receptors
@ast
Behavioral evidence for intera ...... tabotropic glutamate receptors
@en
Behavioral evidence for intera ...... tabotropic glutamate receptors
@nl
type
label
Behavioral evidence for intera ...... tabotropic glutamate receptors
@ast
Behavioral evidence for intera ...... tabotropic glutamate receptors
@en
Behavioral evidence for intera ...... tabotropic glutamate receptors
@nl
prefLabel
Behavioral evidence for intera ...... tabotropic glutamate receptors
@ast
Behavioral evidence for intera ...... tabotropic glutamate receptors
@en
Behavioral evidence for intera ...... tabotropic glutamate receptors
@nl
P3181
P1476
Behavioral evidence for intera ...... tabotropic glutamate receptors
@en
P2093
J C Gewirtz
P304
P3181
P356
10.1016/S0893-133X(00)00136-6
P407
P577
2000-11-01T00:00:00Z
P6179
1039273711